ArticleInternational journal of hematology2020

Elevated C-reactive protein level is associated with poor prognosis in follicular lymphoma patients undergoing rituximab-containing chemotherapy.

Yukiko Kawaguchi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.